Chojnacka-Wójcik E - Search Results

1

Pharmacological analysis of the hypothermic effects of NAN-190 and its analogs, postsynaptic 5-HT1A receptor antagonists, in mice.

Wesołowska A, Borycz J, Paluchowska MH, Chojnacka-Wójcik E. Wesołowska A, et al. Pol J Pharmacol. 2002 Jul-Aug;54(4):391-9. Pol J Pharmacol. 2002. PMID: 12523493 Free article.

2

Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats.

Wesołowska A, Paluchowska MH, Gołembiowska K, Chojnacka-Wójcik E. Wesołowska A, et al. J Pharm Pharmacol. 2003 Apr;55(4):533-43. doi: 10.1211/0022357021017. J Pharm Pharmacol. 2003. PMID: 12803776

3

Involvement of presynaptic 5-HT(1A) and benzodiazepine receptors in the anticonflict activity of 5-HT(1A) receptor antagonists.

Wesołowska A, Paluchowska M, Chojnacka-Wójcik E. Wesołowska A, et al. Eur J Pharmacol. 2003 Jun 13;471(1):27-34. doi: 10.1016/s0014-2999(03)01814-4. Eur J Pharmacol. 2003. PMID: 12809949

4

Novel N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]-ethyl]pyrid-2(1H)-ones with diversified 5-HT1A receptor activity.

Paluchowska MH, Bugno R, Charakchieva-Minol S, Wesołowska A, Chojnacka-Wójcik E. Paluchowska MH, et al. Pol J Pharmacol. 2002 Nov-Dec;54(6):641-6. Pol J Pharmacol. 2002. PMID: 12866719 Free article.

5

Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.

Paluchowska MH, Mokrosz MJ, Charakchieva-Minol S, Duszyńska B, Kozioł A, Wesołowska A, Stachowicz K, Chojnacka-Wójcik E. Paluchowska MH, et al. Pol J Pharmacol. 2003 Jul-Aug;55(4):543-52. Pol J Pharmacol. 2003. PMID: 14581712 Free article.

6

New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.

Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E. Paluchowska MH, et al. Pol J Pharmacol. 2004 Nov-Dec;56(6):743-54. Pol J Pharmacol. 2004. PMID: 15662087 Free article.

7

Novel, flexible, and conformationally defined analogs of gepirone: synthesis and 5-HT1A, 5-HT2A, and D2 receptor activity.

Paluchowska MH, Bugno R, Bojarski AJ, Charakchieva-Minol S, Duszyńska B, Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E. Paluchowska MH, et al. Bioorg Med Chem. 2005 Feb 15;13(4):1195-200. doi: 10.1016/j.bmc.2004.11.019. Bioorg Med Chem. 2005. PMID: 15670928

8

1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.

Bojarski AJ, Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E. Bojarski AJ, et al. Bioorg Med Chem. 2005 Mar 15;13(6):2293-303. doi: 10.1016/j.bmc.2004.12.041. Bioorg Med Chem. 2005. PMID: 15727878

9

Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity.

Bojarski AJ, Paluchowska MH, Duszyńska B, Bugno R, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E. Bojarski AJ, et al. Bioorg Med Chem. 2006 Mar 1;14(5):1391-402. doi: 10.1016/j.bmc.2005.09.060. Epub 2005 Nov 2. Bioorg Med Chem. 2006. PMID: 16266808

10

Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice.

Wesołowska A, Nikiforuk A, Chojnacka-Wójcik E. Wesołowska A, et al. Eur J Pharmacol. 2006 Jul 10;541(1-2):57-63. doi: 10.1016/j.ejphar.2006.04.049. Epub 2006 May 7. Eur J Pharmacol. 2006. PMID: 16765343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page